A Battle of Choices | A19 Ran vs. A9 Medicine in the Fan Debate
As chatter heats up, fans are debating whether to pull for A19 Ran or A9 Medicine from the latest character lineup. Discontent grows as players weigh the strengths and weaknesses of these units ahead of upcoming releases.
The Lowdown on A19 Ran
A19 Ran remains a typical FES character with a speed focus but is criticized for lacking durability. While her skill set features several buffs and debuffs that can enhance team performance, players are concerned.
"Ran is a fox, but where are the cubes?"
Reports indicate she pairs with Youkai killers, yet her dual-scaling ATK buffs and accuracy problems hinder her effectiveness—landing her in the low C tier. Despite many players claiming that a 60gc step-up might be justified, overall sentiment suggests she struggles in versatility.
A9 Medicine's Appeal
Conversely, A9 Medicine showcases an AoE 2 Yin Def II debuff skill, which some fans praise for its synergy with burn applications. Despite her strengths, players argue her true potential is diminished by a lack of suitable ATK buffs and her limited ability to damage foes effectively.
One fan questioned,
"Medicine using burn rather than poison seems off theme, don't really like that."
While she shines in niche scenarios like DS 120 stages, the community sentiment warns that her limitations may not justify a pull. Currently, she’s rated a low B, specifically useful against humans. Community input suggests that the upcoming EX Mamizou is a much better option, with one fan stating,
"Next week will bring the best EX Fes unit in the game."
Rising Sentiment on Future Characters
Fans have varying opinions, expressing hope and disappointment regarding these characters. Some lean towards their favorites despite the tier ratings. Notably, speculation is growing around the next EX Mamizou release—expected to eclipse the current offerings.
Key Points from the Discussion
✅ A19 Ran's versatility plummets; limited execution power hinders her.
🚫 A9 Medicine’s capabilities shine in restricted scenarios; weaknesses overshadow her utility.
💬 "Best of luck to those pulling for Ran and/or Medicine!" highlights mixed community sentiment on these choices.
Looking Ahead
The fan community appears to be leaning towards newer releases, with estimates suggesting about 60% may save their resources for the elite EX Mamizou. The sentiment is likely to swing towards characters that combine power and aesthetics, leading to fluctuating interest levels.
Community's Emotional Attachments
Interestingly, comparisons are being drawn to sports drafts, where teams must balance star power against needs. This reflects a broader trend—the emotional attachment fans have for characters may outweigh statistical performance. While opinions vary, the community's passion for both Ran and Medicine remains evident, fostering a lively debate.